President Obama’s signature legislation from his first term was the Affordable Care Act, which has wide-ranging effects.
Claim Construction at the Federal Circuit in the Wake of the Supreme Court’s Ruling in Teva v. Sandoz
Whether your company is a plaintiff or defendant in a patent litigation, claim construction is often a critical point in the case.
If your company has been sued recently for patent infringement, then you have undoubtedly investigated the possibility of challenging the asserted patents in an Inter Partes Review (IPR). IPR is one of several new procedures available in the U.S. Patent and Trademark Office (USPTO), which allow for a “post-grant” attack...
A recent decision from the Delaware District Court held that the composition of matter patent for the drug Baraclude was invalid as obvious. This opinion has drawn immediate attention because it is the first time that a lead compound obviousness challenge has succeeded in a district court since KSR v....